Strategic Collaborations in Chronic Pain and Opioid Use Disorder Treatment

Collaborations Between Chronic Pain and Opioid Use Disorder Companies

Vincent points out two notable collaborations: Vori Health, a multidisciplinary musculoskeletal care company, partnering with Ophelia Health, which specializes in opioid use disorder; and Override Health, a chronic pain coaching company, joining forces with Bicycle Health, also focused on opioid use disorder. These partnerships reflect a strategic merging of expertise in chronic pain management and opioid use disorder treatment.

Impact of Extended Telehealth Prescribing Rules

The DEA’s extension of telehealth prescribing rules for controlled substances plays a crucial role in these collaborations. It enables companies like Vori Health and Override Health to continue prescribing medications such as buprenorphine and suboxone, which are essential for treating opioid use disorder, through telehealth platforms.

The Future of Telehealth in Treating Opioid Use Disorder

Vincent expresses optimism about the potential of telehealth in addressing opioid use disorder, considering it a promising use case. He anticipates more companies in the chronic pain space will form similar collaborations, driven by the large addressable market and the pressing need for effective treatment solutions.